Penicillamine → 4-Thiazolidinecarboxylic acid, 2-(2-(dimethylamino)-2-oxoethyl)-2,5,5-trimethyl-

HRID 434548

반응식

HRID 434548 반응식
[NH2:1][C@@H:2]([C:7]([OH:9])=[O:8])[C:3]([SH:6])([CH3:5])[CH3:4].[CH3:10][N:11]([CH3:18])[C:12](=[O:17])[CH2:13][C:14]([CH3:16])=O.S([O-])([O-])(=O)=O.[Mg+2]>C1C=CC=CC=1>[CH3:4][C:3]1([CH3:5])[S:6][C:14]([CH2:13][C:12]([N:11]([CH3:18])[CH3:10])=[O:17])([CH3:16])[NH:1][CH:2]1[C:7]([OH:9])=[O:8]

참가 물질

5

반응물 3

HCID 5852PenicillamineHCID 16278DimethylacetoacetamideHCID 24083Sulfuric acid magnesium salt (1:1)

생성물 1

HCID 30699314-Thiazolidinecarboxylic acid, 2-(2-(dimethylamino)-2-oxoethyl)-2,5,5-trimethyl-수율 66%

시약·촉매·용매 1

HCID 241Benzene용매

실험 절차

A suspension of 2.00 g (13.4 mmoles) of D-penicillamine and 1.73 g (13.4 mmoles) of N,N-dimethylacetoacetamide in 15 ml of dry benzene, and 0.6 g of anhydrous magnesium sulfate was refluxed for 3.5 hours under a stream of argon. The reaction mixture became clear and then the solvent was distilled off. The resulting residue was dissolved in hot methyl alcohol. Insolubles were removed by filtration and the solvent was again distilled off. The residue was crystallized from chloroform and further recrystallized from ethyl alcohol-ether to give 2.3 g of 4-carboxy-2,5,5-trimethylthiazolidine-2-N,N-dimethylacetamide as colorless prisms.

후처리

  1. temperaturewas refluxed for 3.5 hours under a stream of argon
  2. distillationthe solvent was distilled off
  3. dissolutionThe resulting residue was dissolved in hot methyl alcohol
  4. customInsolubles were removed by filtration
  5. distillationthe solvent was again distilled off
  6. customThe residue was crystallized from chloroform
  7. customfurther recrystallized from ethyl alcohol-ether

출처 및 근거

ORD 기록
ord-dea7b4a90e8c42ab96f85ff15f067179
출처 데이터셋
uspto-grants-1983_08
특허 번호
US04398026

연결된 노트

불러오는 중…